ArticlemBio2025
Deciphering the viral landscape in gastric cancer: comprehensive characterization and identification of the gastric cancer virome.
Article in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Comprehensive analysis of the gastric metatranscriptome reveals specific viral signatures associated with gastric cancer.International microbiology : the official journal of the Spanish Society for Microbiology · 2026Article
- Gastric Microbiota Dysbiosis and Microbiome-Based Interventions in Chronic Atrophic Gastritis.Nutrients · 2026Review
- The research progress of the synergistic effect of Epstein-Barr virus andFrontiers in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
Infectious diseases caused by pathogenic microorganisms and tumors arising from uncontrolled cell proliferation can be intricately linked through the lens of viromics. This study aimed to delineate the landscape of viral infections in gastric cancer, focusing on the relationship between pathogenic microorganisms and tumorigenesis. By conducting transcriptomic sequencing of gastric cancer tissues, we identified gastric cancer-associated viruses from raw transcriptomic data. This methodology was validated using public databases and experimental evidence, ensuring the authenticity of viral detection. Single-cell data further identified specific cells harboring these viruses and elucidated the correlation between viral gene expression and the genesis and progression of gastric cancer. Common tumor viruses, such as human endogenous retrovirus (HERV), Epstein-Barr virus (EBV), and human cytomegalovirus (HCMV), along with unique DNA viruses and bacteriophages, were detected in gastric cancer. Additionally, these viruses have been detected in both tumor and immune cells, indicating a close association between viral gene expression and the development of gastric cancer. This study advances the technique of screening viruses from transcriptomes, charting the distribution of viruses within tumors, clarifying the interplay between viruses and cancer, and identifying previously unknown viruses related to the occurrence and progression of cancer. IMPORTANCE: In our study, we have carefully examined the viral landscape in gastric cancer, supported by a series of thorough experiments that verify its reliability. Our approach has not only confirmed the presence of viruses known to be associated with cancer development but also identified a range of additional viral entities, including human cytomegalovirus (HCMV) and various herpesviruses, along with numerous bacteriophages. The high incidence of these viruses within tumor samples suggests they could be considered as potential biomarkers for early cancer detection. This method enhances our understanding of the role viruses play in cancer, which may assist scientists and medical professionals in identifying viral presence in cancers and could offer new angles for cancer prevention and the development of related measures. By identifying specific viruses linked to different cancers, we aim to improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.